Regulations.gov document
Improving the Implementation of Risk-Based Monitoring Approaches of Clinical…
Notice · FDA-2019-N-0001 · posted May 31, 2019
Key facts
| Document ID | FDA-2019-N-0001-0003 |
|---|---|
| Title | Improving the Implementation of Risk-Based Monitoring Approaches of Clinical Investigations; Public Workshop |
| Document type | Notice |
| Subtype | Meeting |
| Agency | FDA |
| Docket | FDA-2019-N-0001 |
| Posted | May 31, 2019 |
| Federal Register citation | 84 FR 25281 |
| FR document number | 2019-11411 |
| Comment period opens | May 31, 2019 |
| Effective date | May 31, 2019 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: